Skip to main content
Top
Published in: Acta Diabetologica 1/2014

01-02-2014 | Original Article

Resting heart rate predicts metabolic syndrome in apparently healthy non-obese Japanese men

Authors: Eiji Oda, Yoshifusa Aizawa

Published in: Acta Diabetologica | Issue 1/2014

Login to get access

Abstract

Autonomic nervous dysfunction is considered to be one of the mechanisms of metabolic syndrome (MetS). The aim of this study is to investigate whether resting heart rate, a marker of autonomic nervous dysfunction, is a predictor of MetS in apparently healthy non-obese [body mass index (BMI) <25 kg/m2] Japanese men. This is an observational study through 3 years in apparently healthy Japanese 1,265 men and 793 women without MetS and with no history of cardiovascular disease and no use of antihypertensive, antidiabetic, or antihyperlipidemic medication at baseline. Hazard ratios (HRs) of incident MetS were calculated for each 1 SD increase in heart rate stratified by gender and obesity. Incidence of MetS for each tertile of heart rate and HRs of MetS for the highest tertile (T3) compared with the lowest tertile (T1) were calculated stratified by gender and obesity. The HRs [95 % confidence intervals (CIs)] of MetS for each 1 SD increase in heart rate were 1.319 (1.035–1.681) (p = 0.025) in non-obese men, 1.172 (0.825–1.665) (p = 0.377) in obese men, 1.115 (0.773–1.608) (p = 0.560) in non-obese women, and 1.401 (0.944–2.078) (p = 0.094) in obese women adjusted for BMI, age, smoking, alcohol drinking, and physical activity. The HRs (95 % CIs) of MetS for T3 were 2.138 (1.071–4.269) (p = 0.031) in non-obese men and 1.341 (0.565–3.180) (p = 0.506) in obese men adjusted for pre-existing five components of MetS, age, smoking, alcohol drinking, and physical activity. In conclusion, an increase in resting heart rate was a significant predictor of MetS in non-obese Japanese men.
Literature
1.
go back to reference Oda E (2012) Metabolic syndrome: its history, mechanisms, and limitations. Acta Diabetol 49:89–95PubMedCrossRef Oda E (2012) Metabolic syndrome: its history, mechanisms, and limitations. Acta Diabetol 49:89–95PubMedCrossRef
2.
go back to reference World Health Organization (1999) Definition, diagnosis, and classification of diabetes mellitus and its complications: report of a WHO Consultation. World Health Organization, Geneva World Health Organization (1999) Definition, diagnosis, and classification of diabetes mellitus and its complications: report of a WHO Consultation. World Health Organization, Geneva
3.
go back to reference Expert Panel on the Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel). JAMA 285:2486–2497CrossRef Expert Panel on the Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel). JAMA 285:2486–2497CrossRef
4.
go back to reference Alberti KGMM, Zimmet P, Shaw J (2006) Metabolic syndrome—a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 23:469–480PubMedCrossRef Alberti KGMM, Zimmet P, Shaw J (2006) Metabolic syndrome—a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 23:469–480PubMedCrossRef
5.
go back to reference Grundy SM, Cleeman JI, Daniels SR et al (2005) Diagnosis and management of the metabolic syndrome: a statement for health care professionals: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112:2735–2752PubMedCrossRef Grundy SM, Cleeman JI, Daniels SR et al (2005) Diagnosis and management of the metabolic syndrome: a statement for health care professionals: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112:2735–2752PubMedCrossRef
6.
go back to reference Alberti KGMM, Eckel RH, Grundy SM et al (2009) Harmonizing the metabolic syndrome. A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640–1645PubMedCrossRef Alberti KGMM, Eckel RH, Grundy SM et al (2009) Harmonizing the metabolic syndrome. A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640–1645PubMedCrossRef
7.
go back to reference Kahn R, Buse J, Ferrannini E, Stern M (2005) The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28:2289–2304PubMedCrossRef Kahn R, Buse J, Ferrannini E, Stern M (2005) The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28:2289–2304PubMedCrossRef
8.
go back to reference Simmons RK, Alberti KG, Gale EA et al (2010) The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia 53:600–605PubMedCrossRef Simmons RK, Alberti KG, Gale EA et al (2010) The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia 53:600–605PubMedCrossRef
9.
go back to reference Oda E (2008) The metabolic syndrome as a concept of adipose tissue disease. Hypertens Res 31:1283–1291PubMedCrossRef Oda E (2008) The metabolic syndrome as a concept of adipose tissue disease. Hypertens Res 31:1283–1291PubMedCrossRef
10.
go back to reference Cinti S, Mitchell G, Barbatelli G et al (2005) Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 46:2347–2355PubMedCrossRef Cinti S, Mitchell G, Barbatelli G et al (2005) Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 46:2347–2355PubMedCrossRef
11.
go back to reference Reaven GM, Lithell H, Landsberg L (1996) Hypertension and associated metabolic abnormalities—the role of insulin resistance and the sympathoadrenal system. N Engl J Med 334:374–381PubMedCrossRef Reaven GM, Lithell H, Landsberg L (1996) Hypertension and associated metabolic abnormalities—the role of insulin resistance and the sympathoadrenal system. N Engl J Med 334:374–381PubMedCrossRef
12.
go back to reference Katagiri H, Yamada T, Oka Y (2007) Adiposity and cardiovascular disorders: disturbance of the regulatory system consisting of humoral and neuronal signals. Circ Res 101:27–39PubMedCrossRef Katagiri H, Yamada T, Oka Y (2007) Adiposity and cardiovascular disorders: disturbance of the regulatory system consisting of humoral and neuronal signals. Circ Res 101:27–39PubMedCrossRef
13.
go back to reference Niijima A (1998) Afferent signals from leptin sensors in the white adipose tissue of the epididymis, and their reflex effect in the rat. J Auton Nerv Syst 73:19–25PubMedCrossRef Niijima A (1998) Afferent signals from leptin sensors in the white adipose tissue of the epididymis, and their reflex effect in the rat. J Auton Nerv Syst 73:19–25PubMedCrossRef
14.
go back to reference Yamada T, Katagiri H, Ishigaki Y et al (2006) Signals from intra-abdominal fat modulate insulin and leptin sensitivity through different mechanisms: neuronal involvement in food-intake regulation. Cell Metab 3:223–229PubMedCrossRef Yamada T, Katagiri H, Ishigaki Y et al (2006) Signals from intra-abdominal fat modulate insulin and leptin sensitivity through different mechanisms: neuronal involvement in food-intake regulation. Cell Metab 3:223–229PubMedCrossRef
15.
go back to reference Carnethon MR, Golden SH, Folsom AR, Haskell W, Liao D (2003) A prospective investigation of autonomic nervous system function and the development of type 2 diabetes: atherosclerosis risk in communities study, 1987–1998. Circulation 107:2190–2195PubMedCrossRef Carnethon MR, Golden SH, Folsom AR, Haskell W, Liao D (2003) A prospective investigation of autonomic nervous system function and the development of type 2 diabetes: atherosclerosis risk in communities study, 1987–1998. Circulation 107:2190–2195PubMedCrossRef
16.
go back to reference Ruderman NB, Schneider SH, Berchtold P (1981) The “metabolically-obese”, normal-weight individual. Am J Clin Nutr 34:1617–1621PubMed Ruderman NB, Schneider SH, Berchtold P (1981) The “metabolically-obese”, normal-weight individual. Am J Clin Nutr 34:1617–1621PubMed
17.
go back to reference The Examination Committee of Criteria for ‘Obesity Disease’ in Japan, Japan Society for the Study of Obesity (2002) New criteria for ‘obesity disease’ in Japan. Circ J 66:987–992CrossRef The Examination Committee of Criteria for ‘Obesity Disease’ in Japan, Japan Society for the Study of Obesity (2002) New criteria for ‘obesity disease’ in Japan. Circ J 66:987–992CrossRef
19.
go back to reference Cnop M, Landchild MJ, Vidal J et al (2002) The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: distinct metabolic effects of two fat compartments. Diabetes 51:1005–1015PubMedCrossRef Cnop M, Landchild MJ, Vidal J et al (2002) The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: distinct metabolic effects of two fat compartments. Diabetes 51:1005–1015PubMedCrossRef
20.
go back to reference Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R (2005) Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111:1448–1454PubMedCrossRef Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R (2005) Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111:1448–1454PubMedCrossRef
21.
go back to reference Kim J, Montagnani M, Koh KK, Quon MJ (2006) Reciprocal relationships between insulin resistance and endothelial dysfunction. Molecular and pathophysiological mechanisms. Circulation 113:1888–1904PubMedCrossRef Kim J, Montagnani M, Koh KK, Quon MJ (2006) Reciprocal relationships between insulin resistance and endothelial dysfunction. Molecular and pathophysiological mechanisms. Circulation 113:1888–1904PubMedCrossRef
22.
go back to reference Inoue T, Oshiro S, Iseki K et al (2001) High heart rate relates to clustering of cardiovascular risk factors in a screened cohort. Jpn Circ J 65:969–973PubMedCrossRef Inoue T, Oshiro S, Iseki K et al (2001) High heart rate relates to clustering of cardiovascular risk factors in a screened cohort. Jpn Circ J 65:969–973PubMedCrossRef
23.
go back to reference Oda E, Kawai R (2009) Significance of heart rate on the prevalence of metabolic syndrome and its related risk factors in Japanese. Circ J 73:1431–1436PubMedCrossRef Oda E, Kawai R (2009) Significance of heart rate on the prevalence of metabolic syndrome and its related risk factors in Japanese. Circ J 73:1431–1436PubMedCrossRef
24.
25.
go back to reference Tomiyama H, Yamada J, Koji Y et al (2007) Heart rate elevation precedes the development of metabolic syndrome in Japanese men: a prospective study. Hypertens Res 30:417–426PubMedCrossRef Tomiyama H, Yamada J, Koji Y et al (2007) Heart rate elevation precedes the development of metabolic syndrome in Japanese men: a prospective study. Hypertens Res 30:417–426PubMedCrossRef
26.
go back to reference Inoue T, Iseki K, Iseki C, Ohya Y, Kinjo K, Takishita S (2009) Effect of heart rate on the risk of developing metabolic syndrome. Hypertens Res 32:801–806PubMedCrossRef Inoue T, Iseki K, Iseki C, Ohya Y, Kinjo K, Takishita S (2009) Effect of heart rate on the risk of developing metabolic syndrome. Hypertens Res 32:801–806PubMedCrossRef
27.
go back to reference Miyawaki T, Abe M, Yahata K, Kajiyama N, Katsuma H, Saito N (2004) Contribution of visceral fat accumulation to the risk factors for atherosclerosis in non-obese Japanese. Intern Med 43:1138–1144PubMedCrossRef Miyawaki T, Abe M, Yahata K, Kajiyama N, Katsuma H, Saito N (2004) Contribution of visceral fat accumulation to the risk factors for atherosclerosis in non-obese Japanese. Intern Med 43:1138–1144PubMedCrossRef
28.
go back to reference Goto T, Onuma T, Takebe K, Kral JG (1995) The influence of fatty liver on insulin clearance and insulin resistance in non-diabetic Japanese subjects. Int J Obes Relat Metab Disord 19:841–845PubMed Goto T, Onuma T, Takebe K, Kral JG (1995) The influence of fatty liver on insulin clearance and insulin resistance in non-diabetic Japanese subjects. Int J Obes Relat Metab Disord 19:841–845PubMed
29.
go back to reference Oda E, Kawai R (2009) Age- and gender-related differences in correlations between abdominal obesity and obesity-related metabolic risk factors in Japanese. Intern Med 48:497–502PubMedCrossRef Oda E, Kawai R (2009) Age- and gender-related differences in correlations between abdominal obesity and obesity-related metabolic risk factors in Japanese. Intern Med 48:497–502PubMedCrossRef
30.
go back to reference Johnson MS, DeMarco VG, Heesch CM et al (2011) Sex differences in baroreflex sensitivity, heart rate variability, and end organ damage in the TGR(mRen2)27 rat. Am J Physiol Heart Circ Physiol 301:H1540–H1550PubMedCrossRef Johnson MS, DeMarco VG, Heesch CM et al (2011) Sex differences in baroreflex sensitivity, heart rate variability, and end organ damage in the TGR(mRen2)27 rat. Am J Physiol Heart Circ Physiol 301:H1540–H1550PubMedCrossRef
31.
go back to reference Fox K, Borer JS, Camm AJ et al (2007) Resting heart rate in cardiovascular disease. J Am Coll Cardiol 50:823–830PubMedCrossRef Fox K, Borer JS, Camm AJ et al (2007) Resting heart rate in cardiovascular disease. J Am Coll Cardiol 50:823–830PubMedCrossRef
32.
go back to reference Tverdal A, Hjellvik V, Selmer R (2008) Heart rate and mortality from cardiovascular causes: a 12 year follow-up study of 379,843 men and women aged 40–45 years. Eur Heart J 29:2772–2781PubMedCrossRef Tverdal A, Hjellvik V, Selmer R (2008) Heart rate and mortality from cardiovascular causes: a 12 year follow-up study of 379,843 men and women aged 40–45 years. Eur Heart J 29:2772–2781PubMedCrossRef
Metadata
Title
Resting heart rate predicts metabolic syndrome in apparently healthy non-obese Japanese men
Authors
Eiji Oda
Yoshifusa Aizawa
Publication date
01-02-2014
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 1/2014
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-013-0503-9

Other articles of this Issue 1/2014

Acta Diabetologica 1/2014 Go to the issue

Thanks to Reviewers

Thanks to Reviewers 2013

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine